{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,16]],"date-time":"2025-10-16T13:46:15Z","timestamp":1760622375076},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2003,3,1]],"date-time":"2003-03-01T00:00:00Z","timestamp":1046476800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chest"],"published-print":{"date-parts":[[2003,3]]},"DOI":"10.1378\/chest.123.3.736","type":"journal-article","created":{"date-parts":[[2003,6,13]],"date-time":"2003-06-13T20:09:19Z","timestamp":1055534959000},"page":"736-739","source":"Crossref","is-referenced-by-count":14,"title":["Use of the Urine Color Test to Monitor Compliance With Isoniazid Treatment of Latent Tuberculosis Infectiona"],"prefix":"10.1016","volume":"123","author":[{"given":"Tal","family":"Eidlitz-Markus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Avraham","family":"Zeharia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerald","family":"Baum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc","family":"Mimouni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Amir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1378\/chest.123.3.736_bib1","series-title":"Mycobacterial diseases (vol 2)","first-page":"2576","article-title":"Principles and practice of infectious diseases","author":"Mandell","year":"2000"},{"key":"10.1378\/chest.123.3.736_bib2","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S0140-6736(96)07493-4","article-title":"Mortality by cause for light regions of the world: global burden of disease study","volume":"349","author":"Murray","year":"1997","journal-title":"Lancet"},{"key":"10.1378\/chest.123.3.736_bib3","first-page":"1376","article-title":"Diagnostic standards and classification of tuberculosis in adults and children: the official statement of the American Thoracic Society","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.3.736_bib4","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1378\/chest.117.3.738","article-title":"Epidemiology and ethnic distribution of multi-resistant tuberculosis in southern Israel 1992\u20131997","volume":"117","author":"Gilad","year":"2000","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.736_bib5","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-126-2-199701150-00005","article-title":"Incidence of tuberculosis in the United States among HIV infected persons","volume":"126","author":"Markowitz","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1378\/chest.123.3.736_bib6","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(00)02124-3","article-title":"Directly observed therapy and treatment adherence","volume":"355","author":"Volmintz","year":"2000","journal-title":"Lancet"},{"key":"10.1378\/chest.123.3.736_bib7","first-page":"425","article-title":"Drug resistant tuberculosis","volume":"163","author":"Long","year":"2000","journal-title":"Can Med Assoc J"},{"key":"10.1378\/chest.123.3.736_bib8","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(99)01439-7","article-title":"The threat of multidrug resistance: is tuberculosis ever untreatable or uncontrollable?","volume":"353","author":"Gleissberg","year":"1999","journal-title":"Lancet"},{"key":"10.1378\/chest.123.3.736_bib9","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1097\/00006454-200005000-00004","article-title":"Twice weekly vs daily chemotherapy for childhood tuberculosis","volume":"19","author":"Water-Naude","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"10.1378\/chest.123.3.736_bib10","first-page":"265","article-title":"Successful intermittent treatment of smear-positive pulmonary tuberculosis in six months: a cooperative study in Poland","volume":"125","author":"Snider","year":"1982","journal-title":"Am Rev Respir Dis"},{"key":"10.1378\/chest.123.3.736_bib11","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1440-1754.1999.00371.x","article-title":"A novel approach to monitoring adherence to preventive therapy for tuberculosis in adolescence","volume":"35","author":"Staar","year":"1999","journal-title":"J Pediatr Child Health"},{"key":"10.1378\/chest.123.3.736_bib12","first-page":"522","article-title":"Official statement of the American Thoracic Society target tuberculosis testing and treatment of latent tuberculosis infection","volume":"161","author":"American Thoracic Society","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1378\/chest.123.3.736_bib13","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1164\/arrd.1972.106.6.923","article-title":"Reagent impregnated paper strip for detection of metabolic products of isoniazid in the urine","volume":"106","author":"Kilburn","year":"1972","journal-title":"Am Respir Rev Dis"},{"key":"10.1378\/chest.123.3.736_bib14","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1378\/chest.98.2.314","article-title":"Testing for isoniazid: an evaluation of the Arkansas Method","volume":"98","author":"Schraufnagel","year":"1990","journal-title":"Chest"},{"key":"10.1378\/chest.123.3.736_bib15","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/S0140-6736(05)63457-5","article-title":"Monitoring compliance with antituberculosis treatment by detection of isoniazid in urine","volume":"350","author":"Elizaga","year":"1997","journal-title":"Lancet"},{"key":"10.1378\/chest.123.3.736_bib16","series-title":"edsBMDP statistical software","author":"Dixon","year":"1992"},{"key":"10.1378\/chest.123.3.736_bib17","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis: a general review","volume":"17","author":"Ferebee","year":"1970","journal-title":"Adv Tuberc Res"},{"key":"10.1378\/chest.123.3.736_bib18","first-page":"984","article-title":"Preventive therapy for tuberculosis in Western Australia","volume":"12","author":"Pang","year":"1998","journal-title":"Int J Tuberc Lung Dis"},{"issue":"suppl","key":"10.1378\/chest.123.3.736_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/0002-9343(85)90085-3","article-title":"Strategies to improve compliance with therapy","volume":"79","author":"Sbarbaro","year":"1985","journal-title":"Am J Med"},{"key":"10.1378\/chest.123.3.736_bib20","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1053\/rmed.1999.0877","article-title":"Tuberculosis preventive therapy: perspective from a multi-ethnic community","volume":"94","author":"Sebastian","year":"2000","journal-title":"Respir Med"}],"container-title":["Chest"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216347389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0012369216347389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T16:24:29Z","timestamp":1553099069000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0012369216347389"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2003,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2003,3]]}},"alternative-id":["S0012369216347389"],"URL":"https:\/\/doi.org\/10.1378\/chest.123.3.736","relation":{},"ISSN":["0012-3692"],"issn-type":[{"value":"0012-3692","type":"print"}],"subject":[],"published":{"date-parts":[[2003,3]]}}}